DexCom Income from Continuous Operations 2010-2025 | DXCM

DexCom annual/quarterly income from continuous operations history and growth rate from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • DexCom income from continuous operations for the quarter ending March 31, 2025 was $0.105B, a 28.01% decline year-over-year.
  • DexCom income from continuous operations for the twelve months ending March 31, 2025 was $0.535B, a 16.28% decline year-over-year.
  • DexCom annual income from continuous operations for 2024 was $0.576B, a 6.41% increase from 2023.
  • DexCom annual income from continuous operations for 2023 was $0.542B, a 58.7% increase from 2022.
  • DexCom annual income from continuous operations for 2022 was $0.341B, a 57.31% increase from 2021.
DexCom Annual Income from Continuous Operations
(Millions of US $)
2024 $576
2023 $542
2022 $341
2021 $217
2020 $550
2019 $101
2018 $-127
2017 $-50
2016 $-66
2015 $-58
2014 $-22
2013 $-30
2012 $-55
2011 $-45
2010 $-55
2009 $-54
DexCom Quarterly Income from Continuous Operations
(Millions of US $)
2025-03-31 $105
2024-12-31 $152
2024-09-30 $135
2024-06-30 $144
2024-03-31 $146
2023-12-31 $256
2023-09-30 $121
2023-06-30 $116
2023-03-31 $49
2022-12-31 $92
2022-09-30 $101
2022-06-30 $51
2022-03-31 $97
2021-12-31 $-5
2021-09-30 $87
2021-06-30 $78
2021-03-31 $57
2020-12-31 $411
2020-09-30 $72
2020-06-30 $46
2020-03-31 $20
2019-12-31 $93
2019-09-30 $46
2019-06-30 $-11
2019-03-31 $-27
2018-12-31 $-180
2018-09-30 $47
2018-06-30 $30
2018-03-31 $-24
2017-12-31 $-9
2017-09-30 $-2
2017-06-30 $3
2017-03-31 $-42
2016-12-31 $-7
2016-09-30 $-19
2016-06-30 $-20
2016-03-31 $-19
2015-12-31 $2
2015-09-30 $-43
2015-06-30 $-4
2015-03-31 $-13
2014-12-31 $1
2014-09-30 $-5
2014-06-30 $-6
2014-03-31 $-13
2013-12-31 $-3
2013-09-30 $-6
2013-06-30 $-10
2013-03-31 $-11
2012-12-31 $-8
2012-09-30 $-17
2012-06-30 $-15
2012-03-31 $-14
2011-12-31 $-12
2011-09-30 $-13
2011-06-30 $-7
2011-03-31 $-12
2010-12-31 $-10
2010-09-30 $-13
2010-06-30 $-12
2010-03-31 $-20
2009-12-31 $-12
2009-09-30 $-14
2009-06-30 $-15
2009-03-31 $-13
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $33.510B $4.033B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $188.546B 82.58
Thermo Fisher Scientific (TMO) United States $162.598B 19.67
Edwards Lifesciences (EW) United States $46.224B 30.31
Alcon (ALC) Switzerland $43.751B 29.57
IDEXX Laboratories (IDXX) United States $43.516B 50.01
IQVIA Holdings (IQV) United States $28.637B 16.04
Mettler-Toledo (MTD) United States $25.693B 30.56
STERIS (STE) Ireland $22.696B 25.00
Waters (WAT) United States $21.023B 29.66
SONOVA HOLDING (SONVY) Switzerland $17.706B 0.00
Hologic (HOLX) United States $14.897B 16.19
Sysmex ADR (SSMXY) Japan $10.505B 29.80
Penumbra (PEN) United States $9.444B 74.12
Masimo (MASI) United States $9.018B 33.26
Globus Medical (GMED) United States $7.825B 18.65
Glaukos (GKOS) United States $6.088B 0.00
Teleflex (TFX) United States $5.300B 8.75
Integer Holdings (ITGR) United States $4.249B 22.26
TransMedics (TMDX) United States $4.221B 91.75
PROCEPT BioRobotics (PRCT) United States $3.276B 0.00
LivaNova (LIVN) United Kingdom $2.545B 15.15
Veracyte (VCYT) United States $2.155B 30.24
Nihon Kohden (NHNKY) Japan $2.134B 24.47
Elekta AB (EKTAY) Sweden $1.961B 17.63
Alphatec Holdings (ATEC) United States $1.693B 0.00
Artivion (AORT) United States $1.390B 130.24
Pulse Biosciences (PLSE) United States $1.152B 0.00
OPKO Health (OPK) United States $1.079B 0.00
Tandem Diabetes Care (TNDM) United States $1.077B 0.00
Integra LifeSciences Holdings (IART) United States $1.023B 5.44
SiBone (SIBN) United States $0.800B 0.00
IRadimed (IRMD) United States $0.756B 38.37
Semler Scientific (SMLR) United States $0.629B 13.64
Beta Bionics (BBNX) United States $0.588B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.567B 8.82
AxoGen (AXGN) United States $0.549B 0.00
OrthoPediatrics (KIDS) United States $0.545B 0.00
Mesa Laboratories (MLAB) United States $0.493B 11.55
Pacific Biosciences Of California (PACB) United States $0.450B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.445B 0.00
Delcath Systems (DCTH) United States $0.437B 0.00
Treace Medical Concepts (TMCI) United States $0.391B 0.00
AngioDynamics (ANGO) United States $0.385B 0.00
RxSight (RXST) United States $0.344B 0.00
ClearPoint Neuro (CLPT) United States $0.335B 0.00
NeuroPace (NPCE) United States $0.334B 0.00
Alpha Tau Medical (DRTS) Israel $0.267B 0.00
908 Devices (MASS) United States $0.259B 0.00
Tactile Systems Technology (TCMD) United States $0.239B 14.45
Neuronetics (STIM) United States $0.234B 0.00
Inogen (INGN) United States $0.197B 0.00
CVRx (CVRX) United States $0.181B 0.00
Sight Sciences (SGHT) United States $0.177B 0.00
Spectral Diagnostics (EDTXF) Canada $0.177B 0.00
Biosig Technologies (BSGM) United States $0.160B 0.00
LENSAR (LNSR) United States $0.155B 0.00
Rapid Micro Biosystems (RPID) United States $0.148B 0.00
Accuray (ARAY) United States $0.145B 0.00
Lucid Diagnostics (LUCD) United States $0.128B 0.00
Anteris Technologies Global (AVR) Australia $0.120B 0.00
Monogram Orthopaedics (MGRM) United States $0.118B 0.00
Atossa Genetics (ATOS) United States $0.115B 0.00
Microbot Medical (MBOT) United States $0.096B 0.00
Spectral AI (MDAI) United States $0.078B 0.00
EnVVeno Medical (NVNO) United States $0.076B 0.00
Sensus Healthcare (SRTS) United States $0.075B 45.80
InspireMD (NSPR) United States $0.074B 0.00
QT Imaging Holdings (QTIH) United States $0.063B 0.00
Hyperfine (HYPR) United States $0.061B 0.00
EDAP TMS S.A (EDAP) France $0.059B 0.00
Covalon Technologies (CVALF) Canada $0.052B 21.22
Vicarious Surgical (RBOT) United States $0.047B 0.00
Precision Optics (POCI) United States $0.038B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
Adagio Medical Holdings (ADGM) United States $0.027B 0.00
Baird Medical Investment Holdings (BDMD) $0.023B 0.00
NexGel (NXGL) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
WORK Medical Technology Group (WOK) China $0.011B 0.00
PAVmed (PAVM) United States $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
Ekso Bionics Holdings (EKSO) United States $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.69